440.26歐元11.44(2.53%)
2022/08/18更新
績效 / 1月5.1%
3月19.18%
1年20.49%
晨星評等 - 1.現金0.72%
- 2.股票9.69%
- 3.債券0.01%
- 4.其他89.58%
- 1.美國89.58%
- 2.歐洲不包含歐元區3.42%
- 3.歐元區1.87%
- 4.新興亞洲1.77%
- 5.加拿大1.65%
- 1.argenx SE ADR5.45%
- 2.Horizon Therapeutics PLC4.83%
- 3.Vertex Pharmaceuticals Inc4.10%
- 4.Seagen Inc Ordinary Shares4.00%
- 5.United Therapeutics Corp3.68%
- 6.Natera Inc3.46%
- 7.Roche Holding AG3.20%
- 8.Neurocrine Biosciences Inc3.14%
- 9.Cytokinetics Inc3.10%
- 10.BioNTech SE ADR3.03%
- 1.現金0.72%
- 2.股票9.69%
- 3.債券0.01%
- 4.其他89.58%
- 1.美國89.58%
- 2.歐洲不包含歐元區3.42%
- 3.歐元區1.87%
- 4.新興亞洲1.77%
- 5.加拿大1.65%
- 1.argenx SE ADR5.45%
- 2.Horizon Therapeutics PLC4.83%
- 3.Vertex Pharmaceuticals Inc4.10%
- 4.Seagen Inc Ordinary Shares4.00%
- 5.United Therapeutics Corp3.68%
- 6.Natera Inc3.46%
- 7.Roche Holding AG3.20%
- 8.Neurocrine Biosciences Inc3.14%
- 9.Cytokinetics Inc3.10%
- 10.BioNTech SE ADR3.03%